1 min read
In the complex landscape of marketing application preparation, data analysis stands as a critical cornerstone that can either propel a submission forward or become its greatest challenge. With shifting deadlines, potential delays in data receipt, and the...
3 min read
Meet Daphne Smyth, Vice President, Global Head of Regulatory Affairs
1 min read
In the complex world of new drug applications (NDAs) and marketing authorization applications (MAAs), success often hinges not on technical expertise alone, but on how well teams work together. While each submission brings its own unique challenges, one...
1 min read
Innovative clinical trial approaches, including adaptive study designs, can play a key role in improving the efficiency of new drug development within biotech and pharma clinical research.
3 min read
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance updates from the US Food & Drug Administration (FDA) that are pertinent to the governance of clinical trials and drug, biologic, or medical device development...
2 min read
Clinical trials are complex, and even well-designed studies may encounter challenges in demonstrating statistical significance.
1 min read
In the intricate dance of preparing marketing applications, the timeline serves as a choreographer, directing countless moving parts into a cohesive submission. Understanding how to craft, manage, and adapt this essential document can mean the difference...
2 min read
Data management plays a formative role in driving clinical development and supporting sponsors' success. Veristat’s flexible global data management approaches enable even the most complex clinical data challenges to be overcome quickly and successfully,...
4 min read
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance updates from the US Food & Drug Administration (FDA) that are pertinent to the governance of clinical trials and drug, biologic, or medical device development...
3 min read
Planning and designing clinical trials conducted in multiple geographic or regulatory regions